This prospective cohort study builds on a currently operational pilot study.
Its specific aims are to: 1) assess survival, health and psychosocial status, cancer and prostate-specific symptoms and cancer recurrence in patients with newly diagnosed prostate cancer at three months and then at yearly intervals after treatment, and to determine biomedical and biopsychosocial correlates of these outcomes; 2) assess factors influencing the initial treatment decision, including characteristics of patients, physicians, and patient-physician interactions;

Agency
National Institute of Health (NIH)
Institute
Agency for Healthcare Research and Quality (AHRQ)
Type
Research Project (R01)
Project #
1R01HS008208-01
Application #
2236603
Study Section
Special Emphasis Panel (HCT)
Project Start
1994-04-01
Project End
1999-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215